‘Global Clinical Trial Supply And Logistics Market Worth $20.7bn In 2021’ Says Visiongain Report

28 August 2018
Pharma

Visiongain’s new report Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027: Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics indicates that the global clinical trial supply and logistics market will see $20.7bn in spending in 2021.

The Global Clinical Trial Supply and Logistics Market is expected to grow at a CAGR of 7.0% from 2016-2021 and CAGR of 5.6% from 2021-2027. The market is expected to grow at a CAGR of 6.2% from 2016 to 2027. The market is estimated at $14.84bn in 2016 and $28.75bn in 2027.
The lead analyst of the report said: “Drug development trends that will affect the clinical trial supply and logistics market in that period include greater biological and orphan drug development. Moreover, demand for clinical-stage cold chain logistics will grow strongly to 2027. Rising need for cold chain logistics will increase demand for new packaging and monitoring technologies that offer lower-cost solutions, including reusable packaging and phase change materials that allow cooling for more-specific temperature ranges.
Clinical trial supply and logistics submarkets in emerging countries will grow faster from 2017, driven by further off-shoring and globalisation of clinical trials by multinational pharmaceutical companies. In the period of 2016-2027, the Chinese clinical trial supply and logistics submarket will grow with a CAGR of 10.8%.”
The 205-page report contains 120 charts that add visual analysis in order to explain the developing trends within the Global Clinical Trial Supply and Logistics Market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments: Manufacturing – also with sub forecasting for packaging and for other production, Logistics and distribution – also with sub forecasts for cold chain logistics and for other services and Supply chain management.
The 205-page report offers market forecasts for the United States (US), Germany, France, the United Kingdom, Italy, Spain, Japan, Brazil, Russia, China, India and Rest of the World.
This report discusses the regulatory outlook for the clinical trial supply chain in the national markets. It also assesses the outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials

Moreover, this report provides qualitative analysis of the clinical trial supply and logistics market and profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry. This report also provides a full transcript of one interview conducted by visiongain with Marken, US.

The report Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027: Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics report will be of value to anyone who wants to better understand the clinical trial supply and logistics market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the clinical trial supply and logistics market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read